CANbridge Pharmaceuticals Revenue

In the year 2024, CANbridge Pharmaceuticals had annual revenue of 85.10M CNY, down -17.27%. CANbridge Pharmaceuticals had revenue of 40.31M in the half year ending December 31, 2024, a decrease of -8.89%.

Revenue

85.10M CNY

Revenue Growth

-17.27%

P/S Ratio

1.36

Revenue / Employee

1.27M CNY

Employees

Market Cap

123.12M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	85.10M	-17.77M	-17.27%
Dec 31, 2023	102.87M	23.90M	30.26%
Dec 31, 2022	78.97M	47.81M	153.43%
Dec 31, 2021	31.16M	19.13M	158.98%
Dec 31, 2020	12.03M	10.56M	719.06%
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
BeOne Medicines	32.49B
Hansoh Pharmaceutical Group Company	13.05B
JD Health International	61.89B
Innovent Biologics	10.03B
WuXi Biologics	19.87B
Sino Biopharmaceutical	30.72B
CSPC Pharmaceutical Group	28.99B
Akeso	2.26B

Revenue Rankings